John G. Hervey

ORCID: 0000-0003-0034-3428
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • International Law and Human Rights
  • Legal Systems and Judicial Processes
  • American Constitutional Law and Politics
  • Legal Education and Practice Innovations
  • International Law and Aviation
  • Legal principles and applications
  • International Maritime Law Issues
  • Cancer survivorship and care
  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • International Arbitration and Investment Law
  • Economic Theory and Institutions
  • Maritime Security and History
  • Global Peace and Security Dynamics
  • Law, logistics, and international trade
  • Breast Cancer Treatment Studies
  • AI in cancer detection
  • Misinformation and Its Impacts
  • Corporate Law and Human Rights
  • Business Law and Ethics
  • Palliative Care and End-of-Life Issues
  • Social Media in Health Education
  • Political Systems and Governance
  • Hepatitis B Virus Studies
  • Economic Policies and Impacts

Inspire Institute
2021

New York State Department of State
2018

St. John's University
2016

Temple University
1930-1933

Temple College
1933

Indiana University
1929-1930

California University of Pennsylvania
1929

Individuals with comorbid conditions have been disproportionately affected by COVID-19. Since regulatory trials of COVID-19 vaccines excluded those immunocompromising conditions, few patients cancer and autoimmune diseases were enrolled. With limited vaccine safety data available, vulnerable populations may conflicted attitudes.We assessed the prevalence independent predictors hesitancy acceptance among individuals serious comorbidities self-reported side effects who had vaccinated.We...

10.2196/29872 article EN cc-by JMIR Public Health and Surveillance 2021-10-20

Abstract Background Discussions regarding palliative care and end-of-life issues are frequently delayed past the time of usefulness, resulting in unwanted medical care. We sought to develop a patient-reported outcome (PRO) instrument that allows patients voice their symptom burdens facilitate timing discussions. Subjects, Materials, Methods A seven-item PRO (Cota Patient Assessed Symptom Score-7 item [CPASS-7]) covering physical performance status, pain, burden, depression was administered...

10.1634/theoncologist.2018-0238 article EN The Oncologist 2018-09-28

Cognitive computing point-of-care decision support tools which ingest patient attributes from electronic health records and display treatment options based on expert training medical literature, supplemented by real world evidence (RWE), might prove useful to novice oncologists. The concordance of augmented intelligence systems with best practices potential influences physician behavior remain unknown.Electronic 88 breast cancer patients evaluated at a USA tertiary care center were presented...

10.1002/cam4.2548 article EN cc-by Cancer Medicine 2019-09-11

10.2307/3307499 article EN University of Pennsylvania Law Review and American Law Register 1930-11-01

10.2307/3308549 article EN University of Pennsylvania Law Review and American Law Register 1936-05-01

Health care transactions depend on the efficiency of digital codes. The International Classification Diseases and Related Problems (ICD) coding system, which is most commonly used fails to capture complexity oncologic diseases. Because important prognostic information such as cancer stage genomic markers are missing, potential for ICD codes define compare patient cohorts severely limited. A more precise, clinically relevant, classification schema that incorporates elements would address...

10.1200/cci.18.00006 article EN JCO Clinical Cancer Informatics 2018-10-16

Abstract Background Individuals with comorbid conditions have been disproportionately affected by COVID-19. Since regulatory clinical trials COVID-19 vaccines excluded those immunocompromising conditions, few patients cancer and autoimmune diseases were enrolled. With limited vaccine safety data available, vulnerable populations may conflicted attitudes. Methods To assess the incidence reasons for hesitancy to early safety, we conducted a cross-sectional online survey, fielded January 15,...

10.1101/2021.04.06.21254014 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2021-04-07

10.2307/3308496 article EN University of Pennsylvania Law Review and American Law Register 1935-04-01

10.1177/000271623819500185 article EN The Annals of the American Academy of Political and Social Science 1938-01-01

10.2307/3308882 article EN University of Pennsylvania Law Review and American Law Register 1941-11-01

10.2307/3308774 article EN University of Pennsylvania Law Review and American Law Register 1939-03-01

<sec> <title>BACKGROUND</title> Individuals with comorbid conditions have been disproportionately affected by COVID-19. Since regulatory trials of COVID-19 vaccines excluded those immunocompromising conditions, few patients cancer and autoimmune diseases were enrolled. With limited vaccine safety data available, vulnerable populations may conflicted attitudes. </sec> <title>OBJECTIVE</title> We assessed the prevalence independent predictors hesitancy acceptance among individuals serious...

10.2196/preprints.29872 preprint EN cc-by 2021-04-23

10.1177/000271622612500169 article EN The Annals of the American Academy of Political and Social Science 1926-05-01

10.1177/000271622914200142 article EN The Annals of the American Academy of Political and Social Science 1929-03-01

10.1177/000271622914100152 article EN The Annals of the American Academy of Political and Social Science 1929-01-01
Coming Soon ...